TY - JOUR
T1 - Global Practices and Preferences in the Use of Osteobiologics for Anterior Cervical Discectomy and Fusion
T2 - A Cross-Sectional Study
AU - AO Spine Knowledge Forum Degenerative
AU - Ambrosio, Luca
AU - Viswanadha, Arun Kumar
AU - Vergroesen, Pieter Paul A.
AU - Buser, Zorica
AU - Meisel, Hans Joerg
AU - Santesso, Nancy
AU - Cheung, Jason P.Y.
AU - Le, Hai V.
AU - Vadalà, Gianluca
AU - Jain, Amit
AU - Demetriades, Andreas K.
AU - Cho, Sam K.
AU - Hsieh, Patrick C.
AU - Diwan, Ashish D.
AU - Martin, Christopher
AU - Yoon, Tim
AU - Muthu, Sathish
N1 - Publisher Copyright:
© The Author(s) 2025. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
PY - 2025/9
Y1 - 2025/9
N2 - Study Design: Cross-sectional study. Objectives: To assess global practices and preferences in the use of osteobiologics for anterior cervical discectomy and fusion (ACDF) and identify factors influencing the choice of specific osteobiologics. Methods: An online survey developed by AO Spine was distributed to spine surgeons worldwide. The survey captured demographic characteristics, osteobiologic use and related information (i.e., previous training, practice patterns, etc.), and factors influencing osteobiologic choice in ACDF. Descriptive statistics, Chi-square tests, and multiple logistic regression were used to analyze responses, focusing on the associations between osteobiologic use and variables such as training, cost awareness, and regional practices. Results: Responses from 458 surgeons revealed regional variability in osteobiologic preferences. Autologous iliac crest bone graft (AICBG) was predominant in Asia Pacific and Middle East, while allograft and demineralized bone matrix were favored in North America and Latin America (P < 0.0001). Over half of the respondents (79.7%) lacked formal training in osteobiologics, and 53.1% were unaware of related costs. Surgeons residing in the Asia Pacific region (OR: 0.47, 95% CI: 0.26-0.84, P = 0.0114), without formal training (OR: 0.53, 95% CI: 0.29-0.97, P = 0.0429), or using cages less often (OR: 0.15, 95% CI: 0.06-0.34, P < 0.0001) were less likely to utilize osteobiologics. Osteobiologic use was also more common when related costs were not an issue for the practitioner (OR: 2.32, 95% CI:1.47-3.70, P = 0.0004). Conclusions: Significant variation exists in osteobiologic use in ACDF across global regions, influenced by surgeon training, cost awareness, and institutional resources. Enhanced training and guidelines could improve consistency in osteobiologic application.
AB - Study Design: Cross-sectional study. Objectives: To assess global practices and preferences in the use of osteobiologics for anterior cervical discectomy and fusion (ACDF) and identify factors influencing the choice of specific osteobiologics. Methods: An online survey developed by AO Spine was distributed to spine surgeons worldwide. The survey captured demographic characteristics, osteobiologic use and related information (i.e., previous training, practice patterns, etc.), and factors influencing osteobiologic choice in ACDF. Descriptive statistics, Chi-square tests, and multiple logistic regression were used to analyze responses, focusing on the associations between osteobiologic use and variables such as training, cost awareness, and regional practices. Results: Responses from 458 surgeons revealed regional variability in osteobiologic preferences. Autologous iliac crest bone graft (AICBG) was predominant in Asia Pacific and Middle East, while allograft and demineralized bone matrix were favored in North America and Latin America (P < 0.0001). Over half of the respondents (79.7%) lacked formal training in osteobiologics, and 53.1% were unaware of related costs. Surgeons residing in the Asia Pacific region (OR: 0.47, 95% CI: 0.26-0.84, P = 0.0114), without formal training (OR: 0.53, 95% CI: 0.29-0.97, P = 0.0429), or using cages less often (OR: 0.15, 95% CI: 0.06-0.34, P < 0.0001) were less likely to utilize osteobiologics. Osteobiologic use was also more common when related costs were not an issue for the practitioner (OR: 2.32, 95% CI:1.47-3.70, P = 0.0004). Conclusions: Significant variation exists in osteobiologic use in ACDF across global regions, influenced by surgeon training, cost awareness, and institutional resources. Enhanced training and guidelines could improve consistency in osteobiologic application.
KW - ACDF
KW - allograft
KW - anterior cervical discectomy and fusion
KW - autograft
KW - bone graft
KW - cervical spine
KW - fusion
KW - osteobiologic
UR - https://www.scopus.com/pages/publications/105000019444
UR - https://www.scopus.com/pages/publications/105000019444#tab=citedBy
U2 - 10.1177/21925682251322417
DO - 10.1177/21925682251322417
M3 - Article
C2 - 39967506
AN - SCOPUS:105000019444
SN - 2192-5682
VL - 15
SP - 3262
EP - 3272
JO - Global Spine Journal
JF - Global Spine Journal
IS - 7
ER -